Chengdu Easton Biopharmaceuticals (688513.SH): Pregabalin Sulfate Tablets Obtained Drug Registration Certificate.
Yuandong Biology (688513.SH) announced that the company has recently received the "Drug Registration Certificate" for the Tabular Mecobalamin Sulfobenzoate Tablets approved and issued by the National Medical Products Administration. The drug is registered as a Category 4 chemical drug and has been approved through consistency evaluation. It is used for the treatment of neuropathic pain in adults with diabetic peripheral neuropathy.
Chengdu Easton Biopharmaceuticals (688513.SH) announced that the company recently received the "Drug Registration Certificate" for the Pregabalin Benzenesulfonate Tablets approved by the National Medical Products Administration. The drug was registered under the category 4 of chemical drugs and was approved through the consistency evaluation. It is used for the treatment of neuropathic pain in adults with diabetes.
Related Articles
HK Stock Market Move | DONGYUE GROUP (00189) rose more than 8%, with the stock price cumulatively increasing nearly 90% this year. Domestic refrigerant prices continue to rise.
HK Stock Market Move | AAC TECH (02018) rises by over 5% again. SRG optical waveguide lenses pass head customer testing and mass production.
BOCOM INTL: AXERA (00600) is given a "buy" rating with a target price of HK$36.
HK Stock Market Move | DONGYUE GROUP (00189) rose more than 8%, with the stock price cumulatively increasing nearly 90% this year. Domestic refrigerant prices continue to rise.
HK Stock Market Move | AAC TECH (02018) rises by over 5% again. SRG optical waveguide lenses pass head customer testing and mass production.
BOCOM INTL: AXERA (00600) is given a "buy" rating with a target price of HK$36.
RECOMMEND
